Like the Human Data Use Case, the Rare Disease Use Case is extending and generalising the system of access authorisation and high volume secure data transfer developed in the EGA (see the Human Data Use Case page for details).
The goal of the Use Case is to create a federated infrastructure that will enable researchers to discover, access and analyse different rare disease repositories across Europe. It is doing this in partnership with other European infrastructure projects, namely RD-CONNECT, BBMRI-ERIC and BBMRI-NL.
What the Use Case does
- Builds a portal through which authorised researchers can access rare disease data from repositories and catalogues around Europe.
- Builds a portfolio of data resources and analysis tools critical for the rare disease research community.
- Implements a technical framework for the comparison and standardisation of services useful for this community.
- Arranges training courses, workshops and hackathons to train rare disease researchers to use ELIXIR services and capture the special service requirements of this community.
ELIXIR Finland and BBMRI
ELIXIR Finland (CSC – IT Center for Science) began a collaboration with BBMRI, becoming the main partner and supplier of IT infrastructure services to the BBMRI national centre in Finland (BBMRI.fi). In 2015 ELIXIR Finland began to run the software that BBMRI uses (e.g. sample availability, consent register, research access management service) within 'ePouta', the secure cloud offered by ELIXIR Finland.
How the Use Case is organised
Serena Scollen is Head of Human Genomics and Translational Data at the ELIXIR Hub. The Rare Disease Use Case work is carried out by Work Package 8 in the ELIXIR EXCELERATE project. The Work Package is led by Ivo Gut and Marco Roos.